Opus Genetics, Inc. Stock Issued During Period, Shares, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for the quarter ending 2026-06-30 was 118.47K shares, a 40.62% increase year-over-year.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for the quarter ending 2026-03-31 was 118.47K shares, a 40.62% increase year-over-year.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for the quarter ending 2025-12-31 was 0.00 shares.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for the quarter ending 2025-09-30 was 0.00 shares.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for fiscal 2025 was 84.24K shares, a 3.70% increase from fiscal 2024.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for fiscal 2024 was 81.23K shares, a 11.30% increase from fiscal 2023.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for fiscal 2023 was 72.99K shares, a 1.90% decline from fiscal 2022.
- Opus Genetics, Inc. stock issued during period, shares, issued for services for fiscal 2022 was 74.40K shares, a 247.42% increase from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Issued for Services 3 month | Stock Issued During Period, Shares, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | 118.47K shares 10-Q · filed 2026-08-06 | 236.93K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 118.47K shares 10-Q · filed 2026-05-12 | 202.71K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 84.24K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | 168.49K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 84.24K shares 10-Q · filed 2026-08-06 | 168.49K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 84.24K shares 10-Q · filed 2026-05-12 | 84.24K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 81.23K shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-12 | 81.23K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 81.23K shares derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | 81.23K shares 10-Q · filed 2025-05-15 | 85.57K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 72.99K shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 72.99K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 4.34K shares 10-Q · filed 2024-08-13 | 125.21K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 68.65K shares 10-Q · filed 2024-05-10 | 135.02K shares derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | 74.40K shares 10-K · filed 2024-03-08 |
| 2022-09-30 | 52.23K shares 10-Q · filed 2023-11-13 | 81.37K shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 14.15K shares 10-Q · filed 2023-08-11 | 34.19K shares derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | 8.02K shares 10-Q · filed 2023-05-15 | 24.96K shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 6.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 21.41K shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 5.05K shares 10-Q · filed 2022-11-04 | |
| 2021-06-30 | 4.92K shares 10-Q · filed 2022-08-12 | |
| 2021-03-31 | 4.47K shares 10-Q · filed 2022-05-13 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 15.00K shares 10-K · filed 2019-03-07 |
| 2018-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 15.00K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 15.00K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2018-03-31 | 7.50K shares 10-Q · filed 2018-05-04 | -52.50K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 15.00K shares 10-K · filed 2019-03-07 |
| 2017-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -282.00K shares derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | -67.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -154.50K shares derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | 75.00K shares 10-Q · filed 2017-05-03 | -27.00K shares derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | -297.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | 33.00K shares 10-K · filed 2018-03-09 |
| 2016-09-30 | 135.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | |
| 2016-06-30 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | |
| 2016-03-31 | 135.00K shares 10-Q · filed 2016-05-06 | |
| 2015-12-31 | 15.00K shares 10-K · filed 2018-03-09 | |
| 2014-12-31 | 400.00K shares 10-K · filed 2017-02-24 | |
| 2013-12-31 | 640.00K shares 10-K · filed 2016-03-14 | |
| 2010-12-31 | 1.70M shares 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |